188 related articles for article (PubMed ID: 18227523)
1. Is anemia of cancer different from chemotherapy-induced anemia?
Steensma DP
J Clin Oncol; 2008 Mar; 26(7):1022-4. PubMed ID: 18227523
[No Abstract] [Full Text] [Related]
2. Erythropoietin: high profile, high scrutiny.
Crawford J
J Clin Oncol; 2007 Mar; 25(9):1021-3. PubMed ID: 17312331
[No Abstract] [Full Text] [Related]
3. Erythropoietin-stimulating agents: new data yield new insights.
Zitella L
Oncology (Williston Park); 2007 Oct; 21(11 Suppl Nurse Ed):36-8. PubMed ID: 18154208
[No Abstract] [Full Text] [Related]
4. Utilizing quality of life as a factor in treatment choices for chemotherapy-induced anemia.
Koopman W; Iakiri S
J Support Oncol; 2005; 3(6 Suppl 4):20-1. PubMed ID: 16355554
[No Abstract] [Full Text] [Related]
5. Epoetin alfa and darbepoetin alfa go head to head.
Steensma DP; Loprinzi CL
J Clin Oncol; 2006 May; 24(15):2233-6. PubMed ID: 16710021
[No Abstract] [Full Text] [Related]
6. Development of a strategy to successfully convert an ambulatory infusion center from epoetin alfa to darbepoetin alfa.
Longfield V; Gebhart B; Hayward L
J Support Oncol; 2005; 3(6 Suppl 4):8-9. PubMed ID: 16355548
[No Abstract] [Full Text] [Related]
7. New ASH/ASCO guidelines on the use of erythropoiesis-stimulating agents: a chorale amid cacophony.
Steensma DP
J Support Oncol; 2007; 5(10):471-3. PubMed ID: 18240668
[No Abstract] [Full Text] [Related]
8. Comment: Epoetin alfa versus darbepoetin alfa for cancer patients with treatment-related anemia.
Yang MC
Ann Pharmacother; 2006 May; 40(5):998-9; author reply 999. PubMed ID: 16670351
[No Abstract] [Full Text] [Related]
9. Darbepoetin alfa and history of thromboembolic events.
Ferretti G; Felici A; Cognetti F
J Clin Oncol; 2009 Nov; 27(33):e211; author reply e212. PubMed ID: 19858373
[No Abstract] [Full Text] [Related]
10. Comparative studies on erythropoietic agents.
Straus D
J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S46-9. PubMed ID: 16280113
[No Abstract] [Full Text] [Related]
11. Erythropoietin, the FDA, and oncology.
Steinbrook R
N Engl J Med; 2007 Jun; 356(24):2448-51. PubMed ID: 17568025
[No Abstract] [Full Text] [Related]
12. [Use of erythropoietin in the treatment of cancer-related anemia].
Huang JX; Meng FJ
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):877-8. PubMed ID: 22335959
[No Abstract] [Full Text] [Related]
13. Darbepoetin alpha coming of age.
Pedrazzoli P; Cinieri S; Lorusso V; Gamucci T; Secondino S; Silvestris N
Anticancer Res; 2007; 27(6C):4419-24. PubMed ID: 18214054
[TBL] [Abstract][Full Text] [Related]
14. Optimizing chemotherapy-induced anemia management with the use of patient flow sheets.
Morehead L; Zobec A; Pacheco-Gach C; Glick R; Flippin SB
J Support Oncol; 2005; 3(6 Suppl 4):14-5. PubMed ID: 16355551
[No Abstract] [Full Text] [Related]
15. Erythropoietin therapy in cancer-related anaemia, yes or no?
Herrmann R
Intern Med J; 2008 Oct; 38(10):749-50. PubMed ID: 19143876
[No Abstract] [Full Text] [Related]
16. Serum hepcidin levels predict response to intravenous iron and darbepoetin in chemotherapy-associated anemia.
Steensma DP; Sasu BJ; Sloan JA; Tomita DK; Loprinzi CL
Blood; 2015 Jun; 125(23):3669-71. PubMed ID: 26045598
[No Abstract] [Full Text] [Related]
17. Cancer- and chemotherapy-induced anemia.
Rodgers GM; Becker PS; Bennett CL; Cella D; Chanan-Khan A; Chesney C; Cleeland C; Coccia PF; Djulbegovic B; Garst JL; Gilreath JA; Kraut EH; Lin WC; Matulonis U; Millenson M; Reinke D; Rosenthal J; Sabbatini P; Schwartz RN; Stein RS; Vij R;
J Natl Compr Canc Netw; 2008 Jul; 6(6):536-64. PubMed ID: 18597709
[No Abstract] [Full Text] [Related]
18. Darbepoetin alfa in the treatment of anemia in cancer patients undergoing chemotherapy.
Wauters I; Vansteenkiste J
Expert Rev Anticancer Ther; 2012 Nov; 12(11):1383-90. PubMed ID: 23113603
[TBL] [Abstract][Full Text] [Related]
19. Darbepoetin alfa: potential role in managing anemia in cancer patients.
Pirker R; Smith R
Expert Rev Anticancer Ther; 2002 Aug; 2(4):377-84. PubMed ID: 12647980
[TBL] [Abstract][Full Text] [Related]
20. [Anemia in patients with cancer].
Kobune M; Kato J; Niitsu Y
Nihon Rinsho; 2008 Mar; 66(3):524-9. PubMed ID: 18330028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
